FANDOM


(clean up)
(clean up)
Line 1: Line 1:
 
{{articletype|perry}}
 
{{articletype|perry}}
   
'''''Valifin''''' was an experimental [[Umbrella Corporation (Perry)|Umbrella]] drug undergoing clinical trials in [[1998]]. It was designed to combat [[Wikipedia:Heart disease|heart disease]] but had a side effect of [[Wikipedia:Kidney failure|kidney failure]].<ref>Perry, ''[[Resident Evil: Zero Hour|Zero Hour]]'', Chapter One.</ref>
+
'''''Valifin''''' was an experimental [[Umbrella Corporation (Perry)|Umbrella]] drug undergoing clinical trials in early [[1998]]. It was designed to combat [[Wikipedia:Heart disease|heart disease]] but had a side effect of [[Wikipedia:Kidney failure|kidney failure]]. This was discovered too late and Umbrella was forced to pay off the family of a girl undergoing the trial.<ref>Perry, ''[[Resident Evil: Zero Hour|Zero Hour]]'', Chapter One.</ref>
   
 
==Sources==
 
==Sources==

Revision as of 16:49, August 22, 2015

Perry universe
(Covers information from the S.D. Perry novels)

Valifin was an experimental Umbrella drug undergoing clinical trials in early 1998. It was designed to combat heart disease but had a side effect of kidney failure. This was discovered too late and Umbrella was forced to pay off the family of a girl undergoing the trial.[1]

Sources

  1. Perry, Zero Hour, Chapter One.

ATTENTION! This article is considered to be a stub page. You can help the Resident Evil Wiki by expanding it.

Community content is available under CC-BY-SA unless otherwise noted.